AzTrials
AzTrials

GeriatricsVMCatNCT05567965

Live Better at Home in Catalonia

A study testing Home care intervention in people with Geriatrics and Home Care Services, run by University of Vic - Central University of Catalonia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The intensity of the home care interventions for dependent older people offered in Spain, and specifically in Catalonia, may not be sufficient to help keep older people at home and delay institutionalisation in a nursing home, but an intensification of the intervention could improve the health and psychosocial state… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Geriatrics, Home Care Services
What is being tested?
Home care intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
No sites listed yet
Study dates
Nov 2022to Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Older people (men and women aged 65 and over).
  • Living in the community.
  • Categorized with a degree II or III of dependency.
  • Users of the public home care without requesting admission to an institution in Catalonia.
  • With a main informal caregiver in charge.
  • The acceptance to participate in the study of the user and the informal caregiver.

Who cannot join

  • Users with privately paid professional carers.
  • Users in palliative care (short life expectancy).

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Live Better at Home (Catalonia): a Randomized Clinical Trial

The intensity of the home care interventions for dependent older people offered in Spain, and specifically in Catalonia, may not be sufficient to help keep older people at home and delay institutionalisation in a nursing home, but an intensification of the intervention could improve the health and psychosocial state of dependent people and their informal caregivers and facilitate their permanence at home.

Read the detailed description

According to recent surveys, more than 80% of older people prefer to live at home, so the current model of care should aim to prolong the autonomy of older people so that they remain as long as possible at home and delay their entry into nursing homes.

The hypothesis of the study is that an intensification of the home care intervention in users with degree II or III of dependency will delay or avoid their institutionalisation in nursing homes.

The main aim of the study is to evaluate the effect of an intensification in home care interventions on users with grade II or III dependency in order to delay or avoid their institutionalisation in a geriatric residence.

Secondary aims are to analyse the effect of an intensification of home care interventions in users with degree II or III of dependency on their health and psychosocial state.To analyse the effect of an intensification of home care intervention together with training for informal caregivers on the health status and overburden of informal caregivers of users with degree II or III of dependency.

To test the impact on the use of resources of an intensification of home care interventions in users with degree II or III of dependency.

A randomised clinical trial with two parallel arms and blinded assessment will be conducted. The duration of follow-up will be 18 months. It will be carried out at the community level in homes in eight municipalities in the province of Barcelona, Catalonia (Spain).

Being tested
Home care intervention
Keywords
Older people, Home care, Functional capacity, Dependence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Home care interventionOther

    The duration of the intervention, both for the control group and the intervention group, will be 18 months or until the user's admission to the nursing home.

Study groups in NCT05567965
Study groupRoleWhat they receive
Intensified home care intervention + TrainingExperimentalUsers will receive an intensification in their home care intervention for dependence, receiving an intervention of a minimum of 1 hour per day and a maximum of 3.5 hours, to support their activities of daily living. The intensification will be personalised according to the specific needs of the user that the professionals consider necessary to attend. The weekly distribution of the intervention will be flexible in terms of timetables, as agreed between professional and informal caregivers. In addition, each informal caregiver will receive multimodal online training with the aim of providing knowledge, skills and attitudes that empower them to face the challenge of caring, guaranteeing quality care, preventing situations that may negatively affect both the person and the family dynamics and enabling an optimal evolution in caregiving.
Receives: Other: Home care intervention
Conventional home care interventionActive comparatorParticipants will continue with their conventional home care intervention for dependence, comprising activities that are mainly carried out at the users' home and are oriented towards supporting their activities of daily living. This intervention is of personalised attention and its average intensity is about 20 minutes per day.
Receives: Other: Home care intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in time from baseline until application for nursing home admission

    To the user. Assessed by asking.

    Measured: Every month up to 18 months. Assessed from the baseline in the study until the application for entry in nursing home, assessed up to 18 months.

Secondary outcomes (8)
  1. Functional capacity

    To the user. Assessed by the Barthel Index. The scoring range is 0 (total dependency)-100 (slight dependency)

    Measured: Every 3 months up to 18 months.

  2. Frailty

    To the user. Assessed by the Frail-VIG index. The scoring range is 0 (no frailty)- 25 (advanced frailty).

    Measured: Every 3 months up to 18 months.

  3. Risk of sarcopenia

    To the user. Assessed by the strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F) questionnaire. The scoring range is 0 - 10 (more than 4 points means risk of sarcopenia).

    Measured: Every 3 months up to 18 months.

  4. Risk of falls

    To the user. Assessed by the Downton Scale. The scoring range is 0 - 14 (more than 3 points means risk of falls).

    Measured: Every 3 months up to 18 months.

  5. Cognitive status

    To the user. Assessed by the Reisberg Global Deterioration Scale. The scoring range is 1 (no dementia)- 7 (late-stage dementia).

    Measured: Every 3 months up to 18 months.

  6. Social network

    To the user. Assessed by the Lubben Social Network Scale. The scoring range is 0 (less social engagement)- 30 (more social engagement).

    Measured: Every 3 months up to 18 months.

  7. Chronic patient experience

    To the user. Assessed by the Chronic Patient Experince Evaluation Instrument (IEXPAC). The scoring range is 0 (worst experience)- 110 (best experience).

    Measured: Every 3 months up to 18 months.

  8. Quality of life related with health

    To the user. Assessed by the EUROQOL-5D-3L. The scoring range is 0 (worst quality of life)- 100 (best quality of life).

    Measured: Every 1 month up to 18 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2022
  2. Study startNov 2022 (estimated)
  3. Primary completionJun 2024 (estimated)
  4. Study completionJun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05567965
Sponsor's protocol ID
VMCCat1.0
Acronym
VMCat
Status last verified
Sep 2022
First submitted
27 Sep 2022
Last updated
5 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected data will result in some publications

Publications

  • Minobes-Molina E, Pamies-Tejedor S, Roncal-Belzunce V, Escalada San Adrian G, Atares Rodriguez L, Garcia-Navarro JA. Multimodal home care intervention for dependent older people "Live better at home": Protocol of a randomized clinical trial. Rev Esp Geriatr Gerontol. 2023 Jul-Aug;58(4):101383. doi: 10.1016/j.regg.2023.101383. Epub 2023 Jul 13.

    PubMed 37453249

Questions about this trial

What is this clinical trial studying?

A study testing Home care intervention in people with Geriatrics and Home Care Services, run by University of Vic - Central University of Catalonia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Eduard Minobes (+34659350407, eduard.minobes@segg.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in time from baseline until application for nursing home admission (time frame: Every month up to 18 months. Assessed from the baseline in the study until the application for entry in nursing home, assessed up to 18 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05567965, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in